osimertinib and Uterine-Neoplasms

osimertinib has been researched along with Uterine-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for osimertinib and Uterine-Neoplasms

ArticleYear
Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    The cervix is a rare site of metastasis from advanced lung adenocarcinoma. Driven gene detection is particularly important for the treatment of advanced lung adenocarcinoma.. A 49-year-old Chinese female was sent to our hospital because of lumbago and sacroiliac joint pain; she was unable to walk and had vaginal bleeding. The following examinations were performed: imaging, colposcopy, bronchoscopy, immunohistochemistry and next-generation sequencing.. According to the clinical manifestations and the examination results, the diagnosis was lung adenocarcinoma with cervical, brain, adrenal gland and bone metastases. More importantly, EGFR gene mutations (del19) were detected in both the primary lung lesion and uterine cervical biopsy specimen.. Osimertinib was chosen as the first-line treatment.. Lumbago and sacroiliac joint pain were significantly relieved. The levels of tumor markers decreased. Primary injuries and metastatic sites were significantly reduced.. Physicians should be alert to the signals of vaginal bleeding and consider that primary lung adenocarcinoma may metastasize to the uterine cervix.

    Topics: Acrylamides; Adenocarcinoma; Aniline Compounds; Antineoplastic Agents; Female; Genes, erbB-1; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Sequence Deletion; Uterine Neoplasms

2020